Back to UBS Group AG UBS Group AG

RVPHRVPH
16 quarters

Position history for UBS Group AGUBS Group AG's holdings in REVIVA PHARMACEUTCLS HLDGS I

UBS Group AG previously held 0 shares of RVPH (REVIVA PHARMACEUTCLS HLDGS I), worth $0 as of 2026-Q2.

Final Value

$0

Final Shares

0

Total Value Change

-$15,000

Total Shares Change

-1,710

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2026-Q2
Latest
Exited
0
-100.0%
$00.0%$0.63
0
2026-Q1
Decreased
5,269
-98.5%
$3,8460.0%$0.22
0
2025-Q4
New
359,455
-
$100,2880.0%$0.28
33
2025-Q3
Exited
0
-100.0%
$00.0%$0.31
0
2025-Q2
Decreased
200
-99.9%
$760.0%$0.34
0
2025-Q1
New
223,541
-
$213,2580.0%$19.08
35
2024-Q4
Exited
0
-100.0%
$00.0%$36.20
0
2024-Q3
Decreased
2,313
-98.3%
$3,3310.0%$28.80
0
2024-Q2
Increased
132,440
+1535.3%
$169,5230.0%$25.60
25
2024-Q1
New
8,099
-
$30,6140.0%$75.60
30
2022-Q1
Exited
0
-100.0%
$00.0%$49.20
0
2021-Q4
Increased
1,964
+24.5%
$6,0000.0%$57.80
13
2021-Q3
Decreased
1,578
-22.4%
$6,0000.0%$81.40
0
2021-Q2
New
2,033
-
$10,0000.0%$97.20
26
2021-Q1
Exited
0
-100.0%
$00.0%$114.80
0
2020-Q4
New
1,710
-
$15,0000.0%$174.90
28

Other major holders of RVPH: MILLENNIUM MANAGEMENT LLC, Woodline Partners LP, Schonfeld Strategic Advisors LLC

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used